These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30188944)

  • 21. Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions.
    Pearson JA; Tai N; Ekanayake-Alper DK; Peng J; Hu Y; Hager K; Compton S; Wong FS; Smith PC; Wen L
    Front Immunol; 2019; 10():2654. PubMed ID: 31798584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunology. Interfering with interferons.
    Wilks J; Golovkina T
    Science; 2015 Jan; 347(6219):233-4. PubMed ID: 25593173
    [No Abstract]   [Full Text] [Related]  

  • 23. One more step toward understanding the immune response to norovirus.
    Lee BE; Pang XL
    J Infect Dis; 2014 Dec; 210(11):1691-2. PubMed ID: 24970847
    [No Abstract]   [Full Text] [Related]  

  • 24. Mendelian resistance to human norovirus infections.
    Le Pendu J; Ruvoën-Clouet N; Kindberg E; Svensson L
    Semin Immunol; 2006 Dec; 18(6):375-86. PubMed ID: 16973373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attach Me If You Can: Murine Norovirus Binds to Commensal Bacteria and Fungi.
    Madrigal JL; Bhar S; Hackett S; Engelken H; Joseph R; Keyhani NO; Jones MK
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32674489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary high-dose murine norovirus 1 infection fails to protect from secondary challenge with homologous virus.
    Liu G; Kahan SM; Jia Y; Karst SM
    J Virol; 2009 Jul; 83(13):6963-8. PubMed ID: 19403675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Norovirus mechanisms of immune antagonism.
    Roth AN; Karst SM
    Curr Opin Virol; 2016 Feb; 16():24-30. PubMed ID: 26673810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enteric bacteria promote human and mouse norovirus infection of B cells.
    Jones MK; Watanabe M; Zhu S; Graves CL; Keyes LR; Grau KR; Gonzalez-Hernandez MB; Iovine NM; Wobus CE; Vinjé J; Tibbetts SA; Wallet SM; Karst SM
    Science; 2014 Nov; 346(6210):755-9. PubMed ID: 25378626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Norovirus in immunocompromised patients.
    Atmar J; Mullen E
    Oncol Nurs Forum; 2013 Sep; 40(5):434-6. PubMed ID: 23989016
    [No Abstract]   [Full Text] [Related]  

  • 30. Virus-Host Interactions Between Nonsecretors and Human Norovirus.
    Lindesmith LC; Brewer-Jensen PD; Mallory ML; Jensen K; Yount BL; Costantini V; Collins MH; Edwards CE; Sheahan TP; Vinjé J; Baric RS
    Cell Mol Gastroenterol Hepatol; 2020; 10(2):245-267. PubMed ID: 32289501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in norovirus biology.
    Karst SM; Wobus CE; Goodfellow IG; Green KY; Virgin HW
    Cell Host Microbe; 2014 Jun; 15(6):668-80. PubMed ID: 24922570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative murine norovirus studies reveal a lack of correlation between intestinal virus titers and enteric pathology.
    Kahan SM; Liu G; Reinhard MK; Hsu CC; Livingston RS; Karst SM
    Virology; 2011 Dec; 421(2):202-10. PubMed ID: 22018636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The formation of P particle increased immunogenicity of norovirus P protein.
    Tan M; Jiang X
    Immunology; 2012 May; 136(1):28-9. PubMed ID: 22257239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical profile of children with norovirus disease in rotavirus vaccine era.
    Wikswo ME; Desai R; Edwards KM; Staat MA; Szilagyi PG; Weinberg GA; Curns AT; Lopman B; Vinjé J; Parashar UD; Payne DC; Hall AJ
    Emerg Infect Dis; 2013 Oct; 19(10):1691-3. PubMed ID: 24047618
    [No Abstract]   [Full Text] [Related]  

  • 35. Norovirus vaccine development: next steps.
    Atmar RL; Estes MK
    Expert Rev Vaccines; 2012 Sep; 11(9):1023-5. PubMed ID: 23151158
    [No Abstract]   [Full Text] [Related]  

  • 36. Differentiation and Protective Capacity of Virus-Specific CD8
    Tomov VT; Palko O; Lau CW; Pattekar A; Sun Y; Tacheva R; Bengsch B; Manne S; Cosma GL; Eisenlohr LC; Nice TJ; Virgin HW; Wherry EJ
    Immunity; 2017 Oct; 47(4):723-738.e5. PubMed ID: 29031786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of rabbit antibodies raised against
    Kulkarni R; Lole K; Chitambar SD
    Indian J Med Res; 2017 Dec; 146(6):788-790. PubMed ID: 29664039
    [No Abstract]   [Full Text] [Related]  

  • 38. Norovirus triggered microbiota-driven mucosal inflammation in interleukin 10-deficient mice.
    Basic M; Keubler LM; Buettner M; Achard M; Breves G; Schröder B; Smoczek A; Jörns A; Wedekind D; Zschemisch NH; Günther C; Neumann D; Lienenklaus S; Weiss S; Hornef MW; Mähler M; Bleich A
    Inflamm Bowel Dis; 2014 Mar; 20(3):431-43. PubMed ID: 24487272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How dangerous are norovirus infections in patients with rheumatic diseases treated with biologics and DMARDs? Follow-up on a local outbreak and comparison with a control cohort.
    Fiehn C; Miehle N
    Ann Rheum Dis; 2014 Apr; 73(4):786-7. PubMed ID: 24276367
    [No Abstract]   [Full Text] [Related]  

  • 40. HOIL1 Is Essential for the Induction of Type I and III Interferons by MDA5 and Regulates Persistent Murine Norovirus Infection.
    MacDuff DA; Baldridge MT; Qaqish AM; Nice TJ; Darbandi AD; Hartley VL; Peterson ST; Miner JJ; Iwai K; Virgin HW
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.